89989-06-0 Usage
Uses
Used in Pharmaceutical Industry:
1-(3-Ethoxyphenyl)-piperazine dihydrochloride is used as an active pharmaceutical ingredient for the development of neurological medications. Its unique reactivity and the presence of the piperazine group contribute to its effectiveness in treating various neurological disorders.
Used in Research Applications:
1-(3-Ethoxyphenyl)-piperazine dihydrochloride is used as a research chemical to study its properties, reactivity, and potential applications in the pharmaceutical and chemical engineering fields. Its versatility and the influence of synthesis processes on its properties make it an essential tool for scientific investigations.
Check Digit Verification of cas no
The CAS Registry Mumber 89989-06-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,9,8 and 9 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 89989-06:
(7*8)+(6*9)+(5*9)+(4*8)+(3*9)+(2*0)+(1*6)=220
220 % 10 = 0
So 89989-06-0 is a valid CAS Registry Number.
InChI:InChI=1/C12H18N2O.2ClH/c1-2-15-12-5-3-4-11(10-12)14-8-6-13-7-9-14;;/h3-5,10,13H,2,6-9H2,1H3;2*1H
89989-06-0Relevant academic research and scientific papers
5-[3-[PIPERAZIN-1-YL]-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS 4 AND 5 INHIBITORS FOR TREATING E.G. OSTEOARTHRITIS
-
Paragraph 0219; 0304, (2018/01/15)
The present invention discloses 5-[3-[piperazin-l-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives according to Formula (I), wherein R1, R2, R3a, R3b, R6a, R6b, the subscript n and Cy are as defined herein. The present invention relates to compounds inhibiting ADAMTS 4 and 5 for the prophylaxis or treatment of inflammatory diseases or diseases involving degradation of cartilage or disruption of cartilage homeostasis, such as e.g. osteoarthritis.
2-aryl indole derivative as antagonists of tachykinins
-
, (2008/06/13)
The present invention relates to compounds of the formula (I): wherein R1a, R1b, R2, R3, R4, R5, X and n are defined herein. The compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis and postherpetic neuralgia.
